301 filings
SC 13G/A
ARDS
Aridis Pharmaceuticals, Inc.
14 Feb 24
Aridis Pharmaceuticals / ARMISTICE CAPITAL ownership change
2:21pm
SC 13G/A
Lind Global Fund II LP
13 Feb 24
Aridis Pharmaceuticals / Lind Global Fund II ownership change
8:02pm
8-K
ARDS
Aridis Pharmaceuticals, Inc.
16 Jan 24
Submission of Matters to a Vote of Security Holders
6:05am
DEFA14A
ARDS
Aridis Pharmaceuticals, Inc.
18 Dec 23
Additional proxy soliciting materials
9:43am
8-K
ARDS
Aridis Pharmaceuticals, Inc.
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
9:40am
DEFA14A
n0ztk5l
15 Dec 23
Additional proxy soliciting materials
5:00pm
8-K
4jvx8f
3 Nov 23
Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results
5:00pm
DEFA14A
be21u73
3 Nov 23
Additional proxy soliciting materials
6:15am
ARS
4qlm15ii1uj9p5i7gv
2 Nov 23
Annual report to shareholders
5:54pm
4
mleq a6xdly6im6z140
19 Sep 23
Aridis Pharmaceuticals / JOHN F HAMILTON ownership change
4:05pm
4
ufm2hwdjsk8040pm750
19 Sep 23
Aridis Pharmaceuticals / Susan Richards Windham-Bannister ownership change
4:05pm
4
xe5tr
19 Sep 23
Aridis Pharmaceuticals / Eric Patzer ownership change
4:05pm
4
77hnpqrf
19 Sep 23
Aridis Pharmaceuticals / Vu Truong ownership change
4:05pm
4
a7peqbyj9gw 7je
19 Sep 23
Aridis Pharmaceuticals / Hasan Jafri ownership change
4:05pm
25-NSE
5y46m3 y63bgd
8 Sep 23
Exchange delisting
10:13am
8-K
ojgn3o ekdkfolj6aet4
7 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
b01v2x7e bap
25 Aug 23
Termination of a Material Definitive Agreement
4:05pm